Behavioral adherence in emerging adults with type 2 diabetes: Ancillary study

新兴成人 2 型糖尿病患者的行为依从性：辅助研究

• 批准号: 9305568
• 负责人: PAULA MARY TRIEF
• 金额: $ 64.61万
• 依托单位: UPSTATE MEDICAL UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-04-01 至 2021-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9305568
• 关键词: 18 year old; 21 year old; Adherence; Adult; Affect; Ancillary Study; Attention; Attitude; Behavior; Behavior Therapy; Behavioral; Belief; Blood Glucose; Chronic Disease; Climacteric; Clinical Trials; Cohort Studies; Communities; Complications of Diabetes Mellitus; Data; Dependence; Development; Diabetes Mellitus; Disease; Disease Management; Enrollment; Epidemic; Face; Family; Funding; Health; Health Care Visit; Healthcare; Home environment; Insulin-Dependent Diabetes Mellitus; Intervention; Interview; Knowledge; Learning; Life; Link; Measures; Minority; Minority Groups; National Institute of Diabetes and Digestive and Kidney Diseases; Non-Insulin-Dependent Diabetes Mellitus; Observational Study; Outcome; Outcome Measure; Participant; Patients; Pharmaceutical Preparations; Phase; Premature Mortality; Public Health; Public Policy; Questionnaires; Recruitment Activity; Regimen; Research; Research Training; Schools; Self Management; Subgroup; Time; Treatment Protocols; Virulent; Visit; Vulnerable Populations; Work; Youth; behavior change; behavioral outcome; blood glucose regulation; cohort; design; early onset; emerging adult; emerging adulthood; evidence base; experience; glycemic control; high risk; insight; low socioeconomic status; medication compliance; member; outcome prediction; pill; psychosocial; research and development; therapy development; young adult

PROJECT SUMMARY/ABSTRACT Type 2 diabetes in youth is a growing public health concern, with evidence that it is even more serious in youth than in adults, and a serious concern in minority and poor communities. A large clinical trial, known as TODAY, has been ongoing and will continue for 5 years. In the TODAY study, youth with type 2 diabetes were treated using three different treatment regimens. Now they are being followed every year to learn how their disease progresses and what factors contribute to poor outcomes (TODAY2). When TODAY started, these youth were less than 18 years of age, but now most of them are considered to be “emerging adults,” in a phase of life during which these young adults must manage many changes, in addition to a serious disease. This study is designed to better understand the challenges and barriers to engaging in healthy behaviors these emerging adults with type 2 diabetes face, especially challenges in taking their medications, and attending healthcare visits. Our specific aims are to develop a full and rich understanding of factors related to medication adherence and healthcare visit attendance, and their relationship to diabetes health outcomes. We will recruit TODAY2 participants (N=350) to take part in this ancillary study at their annual TODAY2 visit. If they agree to participate, they will complete questionnaires (about their attitudes, beliefs, and behaviors), participate in unannounced pill counts (to measure their medication adherence), and agree to share other information that is routinely gathered for the TODAY2 study (for example, their blood glucose control levels). They will be assessed two times, one year apart. A subset of them (n=60) will also participate in interviews with trained research staff to describe their experience of living with type 2 diabetes. These data and themes that emerge from the interviews will provide important insights into how they cope and manage their diabetes. By understanding emerging adults with type 2 diabetes better, we will move towards the long term objectives of being able to provide meaningful guidance for the development of interventions that can help them achieve successful diabetes self-management, and for the public policies to support them.

项目总结/摘要 青年2型糖尿病是一个日益增长的公共卫生问题，有证据表明，它在青年中更为严重 在少数民族和贫困社区，这是一个严重的问题。一项大型临床试验， 现在已经开始，并将持续5年。在今天的研究中，患有2型糖尿病的年轻人 使用三种不同的治疗方案治疗。现在，他们每年都被跟踪，以了解他们的 疾病进展以及导致不良结局的因素（TODAY 2）。当今天开始时，这些 年轻人不到18岁，但现在他们中的大多数被认为是“新兴的成年人”， 这些年轻的成年人必须管理许多变化，除了严重的疾病。这 这项研究旨在更好地了解从事健康行为的挑战和障碍， 2型糖尿病患者面临的挑战，尤其是在服用药物和参加 保健访问。我们的具体目标是发展一个完整的和丰富的了解有关的因素用药 依从性和医疗就诊率，以及它们与糖尿病健康结果的关系。我们将招募 TODAY 2受试者（N=350）在其年度TODAY 2访视时参加本辅助研究。如果他们同意 参与，他们将完成问卷（关于他们的态度，信仰和行为），参与 未经宣布的药丸计数（以衡量他们的药物依从性），并同意分享其他信息， TODAY 2研究常规收集的数据（例如，血糖控制水平）。他们将 评估了两次，相隔一年。他们中的一个子集（n=60）也将参加与训练有素的 研究人员描述他们与2型糖尿病生活的经历。这些出现的数据和主题 这些访谈将为他们如何科普和管理糖尿病提供重要的见解。通过 为了更好地了解新出现的2型糖尿病成人患者，我们将朝着以下长期目标迈进： 能够为制定干预措施提供有意义的指导， 成功的糖尿病自我管理，以及支持他们的公共政策。